메뉴 건너뛰기




Volumn 36, Issue 10, 2010, Pages 1245-1252

Design of self-microemulsifying drug delivery systems using a high-throughput formulation screening system

Author keywords

Formulation design; High throughput formulation screening; Microemulsion; Self microemulsifying drug delivery system; Turbidity

Indexed keywords

NILVADIPINE; OIL; SURFACTANT;

EID: 77956409237     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639041003710169     Document Type: Article
Times cited : (10)

References (27)
  • 1
    • 0000009718 scopus 로고
    • Microemulsions
    • Swarbrick J, Boylan JC, eds. New York: Marcel Dekker
    • Eccleston GM. (1992). Microemulsions. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology, vol. 9. New York: Marcel Dekker, 375-421.
    • (1992) Encyclopedia of Pharmaceutical Technology , vol.9 , pp. 375-421
    • Eccleston, G.M.1
  • 2
    • 19044386704 scopus 로고    scopus 로고
    • Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxystearate: Evaluation of accelerated and long-term stability
    • Jumaa M, Muller BW. (2002). Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxystearate: Evaluation of accelerated and long-term stability. Eur J Pharm Biopharm, 54:207-12.
    • (2002) Eur J Pharm Biopharm , vol.54 , pp. 207-712
    • Jumaa, M.1    Muller, B.W.2
  • 3
    • 27644483201 scopus 로고    scopus 로고
    • The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds
    • Araya H, Tomita M, Hayashi M. (2005). The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds. Int J Pharm, 305:61-74.
    • (2005) Int J Pharm , vol.305 , pp. 61-74
    • Araya, H.1    Tomita, M.2    Hayashi, M.3
  • 4
    • 0026586447 scopus 로고
    • Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound
    • Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. (1992). Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res, 9:87-93.
    • (1992) Pharm Res , vol.9 , pp. 87-93
    • Charman, S.A.1    Charman, W.N.2    Rogge, M.C.3    Wilson, T.D.4    Dutko, F.J.5    Pouton, C.W.6
  • 5
    • 0033812424 scopus 로고    scopus 로고
    • Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts
    • Charman WN. (2000). Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. J Pharm Sci, 89:967-78.
    • (2000) J Pharm Sci , vol.89 , pp. 967-978
    • Charman, W.N.1
  • 6
    • 0032498581 scopus 로고    scopus 로고
    • Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A
    • Gao Z-G, Choi H-G, Shin H-J, Park K-M, Lim S-J, Hwang K-J, et al. (1998). Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm, 161:75-86.
    • (1998) Int J Pharm , vol.161 , pp. 75-86
    • Gao, Z.-G.1    Choi, H.-G.2    Shin, H.-J.3    Park, K.-M.4    Lim, S.-J.5    Hwang, K.-J.6
  • 7
    • 0031914282 scopus 로고    scopus 로고
    • Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor
    • Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, et al. (1998). Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164-9.
    • (1998) J Pharm Sci , vol.87 , pp. 164-169
    • Hauss, D.J.1    Fogal, S.E.2    Ficorilli, J.V.3    Price, C.A.4    Roy, T.5    Jayaraj, A.A.6
  • 8
    • 0031798010 scopus 로고    scopus 로고
    • Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole
    • Khoo SM, Porter JH, Edwards GA, Charman WN. (1998). Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole. J Pharm Sci, 87:1538-41.
    • (1998) J Pharm Sci , vol.87 , pp. 1538-1541
    • Khoo, S.M.1    Porter, J.H.2    Edwards, G.A.3    Charman, W.N.4
  • 9
    • 4344578729 scopus 로고    scopus 로고
    • Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation
    • Porter CJ, Kaukonen AM, Boyd BJ, Edwards GA, Charman WN. (2004). Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res, 21:1405-12.
    • (2004) Pharm Res , vol.21 , pp. 1405-1412
    • Porter, C.J.1    Kaukonen, A.M.2    Boyd, B.J.3    Edwards, G.A.4    Charman, W.N.5
  • 10
    • 0033805858 scopus 로고    scopus 로고
    • Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems
    • Pouton CW. (2000). Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci, 11(Suppl. 2):S93-8.
    • (2000) Eur J Pharm Sci , vol.11 , Issue.SUPPL. 2
    • Pouton, C.W.1
  • 11
    • 67049143460 scopus 로고    scopus 로고
    • Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine
    • Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm, 35:603-11.
    • (2009) Drug Dev Ind Pharm , vol.35 , pp. 603-611
    • Cui, S.X.1    Nie, S.F.2    Li, L.3    Wang, C.G.4    Pan, W.S.5    Sun, J.P.6
  • 12
    • 77749268044 scopus 로고    scopus 로고
    • Development of microemulsion of mitotane for improvement of oral bioavailability
    • Attivi D, Ajana I, Astier A, Demore B, Gibaud S. (2009). Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm, 36:421-27.
    • (2009) Drug Dev Ind Pharm , vol.36 , pp. 421-427
    • Attivi, D.1    Ajana, I.2    Astier, A.3    Demore, B.4    Gibaud, S.5
  • 13
    • 37549031769 scopus 로고    scopus 로고
    • Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS)
    • Patel D, Sawant KK. (2007). Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm, 33:1318-26.
    • (2007) Drug Dev Ind Pharm , vol.33 , pp. 1318-1326
    • Patel, D.1    Sawant, K.K.2
  • 14
    • 60749119779 scopus 로고    scopus 로고
    • The use of liquid self-microemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin
    • Ofokansi KC, Chukwu KI, Ugwuanyi SI. (2009). The use of liquid self-microemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin. Drug Dev Ind Pharm, 35:185-91.
    • (2009) Drug Dev Ind Pharm , vol.35 , pp. 185-191
    • Ofokansi, K.C.1    Chukwu, K.I.2    Ugwuanyi, S.I.3
  • 15
    • 70350597672 scopus 로고    scopus 로고
    • High-throughput formulation screening system for self-microemulsifying drug delivery
    • Sakai K, Maeda H, Yoshimori T, Obata K, Ogawa Y. (2009). High-throughput formulation screening system for self-microemulsifying drug delivery. Drug Dev Ind Pharm, 35:746-55.
    • (2009) Drug Dev Ind Pharm , vol.35 , pp. 746-55
    • Sakai, K.1    Maeda, H.2    Yoshimori, T.3    Obata, K.4    Ogawa, Y.5
  • 16
    • 77956406282 scopus 로고    scopus 로고
    • Highthroughput formulation screening for designing self-microemulsifying drug delivery system in drug discovery/development stages
    • Nashville
    • Sakai K, Yoshimori T, Maeda H, Ogawa Y (2005). Highthroughput formulation screening for designing self-microemulsifying drug delivery system in drug discovery/development stages. 2005 AAPS Annual Meeting and Exposition, Nashville, W5162.
    • (2005) 2005 AAPS Annual Meeting and Exposition
    • Sakai, K.1    Yoshimori, T.2    Maeda, H.3    Ogawa, Y.4
  • 17
    • 39149091886 scopus 로고    scopus 로고
    • Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs
    • Cuine JF, McEvoy CL, Charman WN, Pouton CW, Edwards GA, Benameur H, et al. (2008). Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci, 97:995-1012.
    • (2008) J Pharm Sci , vol.97 , pp. 995-1012
    • Cuine, J.F.1    McEvoy, C.L.2    Charman, W.N.3    Pouton, C.W.4    Edwards, G.A.5    Benameur, H.6
  • 18
    • 0031573912 scopus 로고    scopus 로고
    • Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose
    • Okimoto K, Miyake M, Ibuki R, Yasumura M, Ohnishi N, Nakai T. (1997). Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. Int J Pharm, 159:85-93.
    • (1997) Int J Pharm , vol.159 , pp. 85-93
    • Okimoto, K.1    Miyake, M.2    Ibuki, R.3    Yasumura, M.4    Ohnishi, N.5    Nakai, T.6
  • 19
    • 0037627337 scopus 로고    scopus 로고
    • Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier
    • Hirasawa N, Ishise S, Miyata H, Danjo K. (2003). Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier. Drug Dev Ind Pharm, 29:339-44.
    • (2003) Drug Dev Ind Pharm , vol.29 , pp. 339-344
    • Hirasawa, N.1    Ishise, S.2    Miyata, H.3    Danjo, K.4
  • 20
    • 0242353023 scopus 로고    scopus 로고
    • An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems
    • Hirasawa N, Ishise S, Miyata H, Danjo K. (2003). An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems. Drug Dev Ind Pharm, 29:997-1004.
    • (2003) Drug Dev Ind Pharm , vol.29 , pp. 997-1004
    • Hirasawa, N.1    Ishise, S.2    Miyata, H.3    Danjo, K.4
  • 21
    • 0025046288 scopus 로고
    • Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat
    • Poelma FG, Breas R, Tukker JJ. (1990). Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat. Pharm Res, 7:392-7.
    • (1990) Pharm Res , vol.7 , pp. 392-397
    • Poelma, F.G.1    Breas, R.2    Tukker, J.J.3
  • 22
    • 0025727540 scopus 로고
    • Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat
    • Poelma FG, Breas R, Tukker JJ, Crommelin DJ. (1991). Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat. J Pharm Pharmacol, 43:317-24.
    • (1991) J Pharm Pharmacol , vol.43 , pp. 317-324
    • Poelma, F.G.1    Breas, R.2    Tukker, J.J.3    Crommelin, D.J.4
  • 23
    • 0028903445 scopus 로고
    • Evaluation of mucosal damage of surfactants in rat jejunum and colon
    • Oberle RL, Moore TJ, Krummel DAP. (1995). Evaluation of mucosal damage of surfactants in rat jejunum and colon. J Pharmacol Toxicol Methods, 33:75-81.
    • (1995) J Pharmacol Toxicol Methods , vol.33 , pp. 75-81
    • Oberle, R.L.1    Moore, T.J.2    Dap, K.3
  • 24
    • 1542406595 scopus 로고    scopus 로고
    • In vitro studies of the effects of HAART drugs and excipients on activity of digestive enzymes
    • Wignot TM, Stewart RP, Schray KJ, Das S, Sipos T. (2004). In vitro studies of the effects of HAART drugs and excipients on activity of digestive enzymes. Pharm Res, 21:420-7.
    • (2004) Pharm Res , vol.21 , pp. 420-427
    • Wignot, T.M.1    Stewart, R.P.2    Schray, K.J.3    Das, S.4    Sipos, T.5
  • 25
    • 4444273107 scopus 로고    scopus 로고
    • Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load
    • Gao P, Witt MJ, Haskell RJ, Zamora KM, Shifflett JR. (2004). Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm Dev Technol, 9:301-9.
    • (2004) Pharm Dev Technol , vol.9 , pp. 301-309
    • Gao, P.1    Witt, M.J.2    Haskell, R.J.3    Zamora, K.M.4    Shifflett, J.R.5
  • 26
    • 34249690584 scopus 로고    scopus 로고
    • In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion
    • Park MJ, Ren S, Lee BJ. (2007). In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion. Biopharm Drug Dispos, 28:199-207.
    • (2007) Biopharm Drug Dispos , vol.28 , pp. 199-207
    • Park, M.J.1    Ren, S.2    Lee, B.J.3
  • 27
    • 29244485443 scopus 로고    scopus 로고
    • A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption
    • Hong JY, Kim JK, Song YK, Park JS, Kim CK. (2006). A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release, 110:332-8.
    • (2006) J Control Release , vol.110 , pp. 332-8
    • Hong, J.Y.1    Kim, J.K.2    Song, Y.K.3    Park, J.S.4    Kim, C.K.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.